PT-141 (10 mg Vial)

Complete dosage protocol and reconstitution guide for PT-141 (10 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
PT-141 (10 mg Vial)

CAT No:

CAS No:

Synonyms/Alias:PT-141

M.F/Formula:

M.W/Mr.:

Purity:Specification by inquiry

Custom Peptide Support
  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Complete dosage protocol and reconstitution guide for PT-141 (10 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water → ~ 3.33 mg/mL concentration.

Typical daily range: 500–1500 mcg once daily (gradual titration over 16 weeks).

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes (27–30G, 5/8-inch needle) for each injection; dispose in a sharps container [7] . Rotate injection sites (abdomen, thighs) on different days to avoid lipodystrophy or irritation [6] . Inject slowly; wait a few seconds before withdrawing the needle. Nausea is the most common side effect and tends to be transient; flushing and headache may also occur [3] . Document daily dose and site rotation to maintain consistency.

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Source URL
https://peptide.cn.com/single-peptide-dosages/pt-141-10-mg-vial-dosage-protocol
Weeks 1–8
Daily Dose (mcg): 500 mcg (0.5 mg) | Units (per injection) (mL): 15 units (0.15 mL)
Weeks 9–12
Daily Dose (mcg): 1000 mcg (1.0 mg) | Units (per injection) (mL): 30 units (0.30 mL)
Weeks 13–16
Daily Dose (mcg): 1500 mcg (1.5 mg) | Units (per injection) (mL): 45 units (0.45 mL)
Long-term Storage Conditions
Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (PT-141, 10 mg each): 8 weeks (56 days × 500 mcg = 28 mg) ≈ 3 vials

12 weeks (56 × 500 + 28 × 1000 = 56 mg) ≈ 6 vials

16 weeks (56 × 500 + 28 × 1000 + 28 × 1500 = 98 mg) ≈ 10 vials

Insulin Syringes (U-100): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle

12 weeks (6 vials): 18 mL → 2 × 10 mL bottles

16 weeks (10 vials): 30 mL → 3 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes

Product Gallery
Quick Inquiry
Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsApp Mia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China